CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.95
+0.03 (+2.92%)
As of Sep 22, 2:41 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 7 58%
Hold 5 42%
Sell 0 0%
Price Target
Analyst Price Target +2,371.6% upside
Low Target $17.63
Average Target $23.50
High Target $33.45
Current Price $0.95
Current
$0.95
Target
$23.50
$17.63 $23.50 avg $33.45
Scenario Analysis
Bear Case
$17.63
1,754.2%
Low target
Base Case
$23.50
+2,371.6%
Avg target
Bull Case
$33.45
+3,418.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.28
-71.0% from high
52-Week Low
$1.18
+-19.4% from low
Target vs 52W High
$23.50
+616.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%